HCM Q1 2018 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$52M-17.3% YoY

Gross Profit

$15M29.2% margin

Operating Income

-$25M-47.8% margin

Net Income

-$12M-22.4% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-53.5%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$485M

Cash & Equivalents

-$358M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$63M	-17.3%
Gross Profit	$15M	$3M	+442.7%
Operating Income	-$25M	-$8M	-211.5%
Net Income	-$12M	$841,000	-1494.8%